1. Insights/
  2. Tigermed-Jyton Supports China NMPA Approval of Meiyan MED’s Cross-linked Sodium Hyaluronate Gel for Injection

Tigermed-Jyton Supports China NMPA Approval of Meiyan MED’s Cross-linked Sodium Hyaluronate Gel for Injection

ContactContact Consultant
Consultants
Beijing Tigermed-Jyton Co., LTD.
Beijing Tigermed-Jyton Co., LTD.Beijing Tigermed-Jyton Co., Ltd. offers "one-stop services" for clinical trials, including project management, clinical monitoring, pharmacovigilance, medical monitoring, data management, statistical analysis, medical writing, and SMO services. This "one-stop" approach ensures higher quality, lower costs, and shorter project timelines, helping sponsors bring their products to market faster.
Categories
01Belgium
02Brazil
03Canada
04China
05France
06Germany
07China (Hong Kong SAR)
08Indonesia
09Israel
10Italy
11Japan
12Macau
13Netherlands
14New Zealand
15North Korea
16Norway
17Pakistan
18Philippines
19Russia
20Singapore
21South Korea
22Spain
23Sweden
24Switzerland
25Thailand
26United Kingdom
27United States
28Life Sciences
Sep 8, 2026Beijing Tigermed-Jyton Co., LTD.
Tigermed-Jyton Supports China NMPA Approval of Meiyan MED’s Cross-linked Sodium Hyaluronate Gel for Injection